Screening of Traditional Chinese Medicines with Therapeutic Potential on Chronic Obstructive Pulmonary Disease Through Inhibiting Oxidative Stress and Inflammatory Response

Ming-Xing Zhou,Xuan Wei,Ai-Ling Li,Ai-Min Wang,Ling-Zi Lu,Yue Yang,Dong-Mei Ren,Xiao-Ning Wang,Xue-Sen Wen,Hong-Xiang Lou,Tao Shen
DOI: https://doi.org/10.1186/s12906-016-1347-y
IF: 4.782
2016-01-01
BMC Complementary and Alternative Medicine
Abstract:Background: Chronic obstructive pulmonary disease (COPD) is a major public health problem and gives arise to severe chronic morbidity and mortality in the world. Inflammatory response and oxidative stress play dominant roles in the pathological mechanism of COPD, and have been regarded to be two important targets for the COPD therapy. Traditional Chinese medicines (TCMs) possess satisfying curative effects on COPD under guidance of the TCM theory in China, and merit in-depth investigations as a resource of lead compounds.Methods: One hundred ninety-six of TCMs were collected, and extracted to establish a TCM extract library, and then further evaluated for their potency on inhibitions of oxidative stress and inflammatory response using NADP(H): quinone oxidoreductase (QR) assay and nitric oxide (NO) production assay, respectively.Results: Our investigation observed that 38 of the tested TCM extracts induced QR activity in hepa 1c1c7 murine hepatoma cells, and 55 of them inhibited NO production in RAW 264.7 murine macrophages at the tested concentrations. Noteworthily, 20 of TCM extracts simultaneously inhibited oxidative stress and inflammatory responses.Conclusion: The observed bioactive TCMs, particularly these 20 TCMs with dual inhibitory effects, might be useful for the treatment of COPD. More importantly, the results of the present research afford us an opportunity to discover new lead molecules as COPD therapeutic agents from these active TCMs.
What problem does this paper attempt to address?